IP Verse

Laboratorios Liconsa competitive analysis

Loading summary...

Explore patent oppositions filed by Laboratorios Liconsa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3453387	Dosage Regimen For A S1P Receptor Agonist	NOVARTIS	Mar 3, 2021
EP3102187	Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets	GALENICUM HEALTH SL	Dec 23, 2020
EP3103448	Pharmaceutical Compositions Comprising An S1P Modulator	NOVARTIS	Apr 3, 2020

Explore the latest publications and patents granted to Laboratorios Liconsa, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Laboratorios Liconsa, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Laboratorios Liconsa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
LABORATORIOS LICONSA	3	-	-	-
GALENICUM HEALTH SL	1	13	-	-
GALENICUM HEALTH SLU	27	13	-	-
NOVARTIS	6	422	-	21